Anlotinib destabilizes PAX3-FOXO1 to induce rhabdomyosarcoma cell death via upregulating NEK2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anlotinib destabilizes PAX3-FOXO1 to induce rhabdomyosarcoma cell death via upregulating NEK2

Published:2024-08 Issue: Volume:177 Page:117126
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Song Zian,Gong Baocheng,Qu Tongyuan^ORCID,Chen Yankun,Zhao Guangzong,Jin Yan,Zhao Qiang

Publisher

Elsevier BV

Reference49 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J. Clin.,2021

2. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification;Missiaglia;J. Clin. Oncol.,2012

3. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma;Williamson;J. Clin. Oncol.,2010

4. Rhabdomyosarcoma;Skapek;Nat. Rev. Dis. Prim.,2019

5. Risk stratification including FOXO1 fusion status (FOXO1) in patients with rhabdomyosarcoma (RMS) treated on six recent frontline trials: a report from the Children's Oncology Group (COG);Hibbitts;J. Clin. Oncol.,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP